SILO PHARMA, INC. Increase (Decrease) in Payables to Broker-Dealers and Clearing Organizations
SILO PHARMA, INC. (SILO) reported Increase (Decrease) in Payables to Broker-Dealers and Clearing Organizations of $16.45 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPayablesToBrokerDealers · last filed 2022-11-10
- SILO PHARMA, INC. increase (decrease) in payables to broker-dealers and clearing organizations for the quarter ending 2022-09-30 was -$24.37K.
- SILO PHARMA, INC. increase (decrease) in payables to broker-dealers and clearing organizations for the quarter ending 2022-06-30 was -$24.02K.
- SILO PHARMA, INC. increase (decrease) in payables to broker-dealers and clearing organizations for the quarter ending 2022-03-31 was $64.84K.
| Period end | Increase (Decrease) in Payables to Broker-Dealers and Clearing Organizations 3 month | Increase (Decrease) in Payables to Broker-Dealers and Clearing Organizations 6 month | Increase (Decrease) in Payables to Broker-Dealers and Clearing Organizations 9 month |
|---|---|---|---|
| 2022-09-30 | -$24.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$48.39K derived: sum of 2 quarters · filed 2022-11-10 | $16.45K 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$24.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | $40.82K 10-Q · filed 2022-08-01 | |
| 2022-03-31 | $64.84K 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |